- Home
- ILMN vs CHYM Comparison
ILMN vs CHYM Comparison
Compare ILMN & CHYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILMN
- CHYM
- Stock Information
- Founded
- ILMN 1998
- CHYM 2012
- Country
- ILMN United States
- CHYM United States
- Employees
- ILMN N/A
- CHYM N/A
- Industry
- ILMN Medical Specialities
- CHYM Finance: Consumer Services
- Sector
- ILMN Health Care
- CHYM Finance
- Exchange
- ILMN Nasdaq
- CHYM Nasdaq
- Market Cap
- ILMN 13.1B
- CHYM 10.8B
- IPO Year
- ILMN 2000
- CHYM 2025
- Fundamental
- Price
- ILMN $96.14
- CHYM $31.55
- Analyst Decision
- ILMN Buy
- CHYM Buy
- Analyst Count
- ILMN 17
- CHYM 13
- Target Price
- ILMN $124.35
- CHYM $37.75
- AVG Volume (30 Days)
- ILMN 2.4M
- CHYM 3.2M
- Earning Date
- ILMN 07-31-2025
- CHYM 08-07-2025
- Dividend Yield
- ILMN N/A
- CHYM N/A
- EPS Growth
- ILMN N/A
- CHYM N/A
- EPS
- ILMN N/A
- CHYM N/A
- Revenue
- ILMN $4,337,000,000.00
- CHYM $1,800,041,000.00
- Revenue This Year
- ILMN N/A
- CHYM $26.40
- Revenue Next Year
- ILMN $3.15
- CHYM $19.67
- P/E Ratio
- ILMN N/A
- CHYM N/A
- Revenue Growth
- ILMN N/A
- CHYM 30.88
- 52 Week Low
- ILMN $68.70
- CHYM $28.21
- 52 Week High
- ILMN $156.66
- CHYM $44.94
- Technical
- Relative Strength Index (RSI)
- ILMN 55.14
- CHYM N/A
- Support Level
- ILMN $95.75
- CHYM N/A
- Resistance Level
- ILMN $99.78
- CHYM N/A
- Average True Range (ATR)
- ILMN 3.15
- CHYM 0.00
- MACD
- ILMN -0.65
- CHYM 0.00
- Stochastic Oscillator
- ILMN 24.97
- CHYM 0.00
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
About CHYM Chime Financial Inc. Class A Common Stock
Chime Financial Inc is a financial technology company that believes in core banking services.